Certain medications used in the treatment of bone conditions, particularly when combined with corticosteroids, may significantly increase the risk of a rare but serious jaw disease. This finding ...

Certain medications used in the treatment of bone conditions, particularly when combined with corticosteroids, may significantly increase the risk of a rare but serious jaw disease.

The Oral Medicine Services team at Fred Hutch Cancer Center addresses the complex oral health needs of patients undergoing ...

The University of Liverpool leads a €8.6M EU project using plant-based biomaterials to treat jawbone damage in cancer pa ...

The University of Liverpool is leading a major €8.6m (£7m) EU-funded research project to tackle a growing medical challenge ...

The University of Liverpool is leading a major €8.6m (£7m) EU-funded research project to tackle a growing medical challenge affecting thousands of cancer survivors: medication-related osteonecrosis of ...

Sam Andrews, 53, a teaching assistant from Corsham in Wiltshire, was diagnosed with secondary breast cancer – which means the ...

Osteoporosis is a disease that makes bones weak and more likely to break. Sometimes, a person may break a bone from a small ...

Denosumab (Prolia) is a leading treatment for osteoporosis, but the rapid bone loss that can occur after discontinuing the ...

Metabolic bone disease articles from ... that larger intervals between intravenous bisphosphonate therapy and dental surgery significantly lowered the risk of jaw osteonecrosis in older ...